Bristol-Myers Squibb Company BMY is scheduled to report first-quarter 2024 results on Apr 25, before market open. In the ...

The chart below, which you can click on for greater detail, shows that Bristol-Myers Squibb had US$39.8b in debt in December ...

Bristol Myers Squibb (NYSE:BMY) on Monday announced a $380M deal with contract manufacturer Cellares to produce CAR T cell ...

(Reuters) - Bristol Myers Squibb and Cellares said on Monday they have reached a $380 million deal to supply CAR-T cell ...

Giovanni Caforio, M.D., is lining up a new gig soon after handing all his Bristol Myers Squibb leadership roles in March. | ...

To get a sense of who is truly in control of Bristol-Myers Squibb Company ( NYSE:BMY ), it is important to understand the ...

Bristol Myers Squibb was the first major biopharma company to take notice of innovative cell therapy contract manufacturer ...

Princeton, New Jersey Tuesday, April 23, 2024, 10:00 Hrs [IST] ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bristol Myers Squibb stock sports an attractive valuation and dividend yield. Is it a more compelling buy than the Vanguard S ...

Bristol Myers Squibb's share price remains stagnant despite regulatory approvals for innovative drugs. Click here to read an ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...